Skip to content

Spotlight: How Do Capital Requirements Affect Loan Rates? Evidence from High Volatility Commercial Real Estate

Regulatory capital requirements for banks have been a topic of heated discussions by academicians, bankers, and policy makers for decades. Central to these discussions is how costly requiring banks to fund themselves with more equity (rather than cheaper deposits) is and how these possible regulatory costs are transmitted to bank borrowers. In a recently published RCFS paper, “How Do Capital Requirements Affect Loan Rates? Evidence from High Volatility Commercial Real… Read More »Spotlight: How Do Capital Requirements Affect Loan Rates? Evidence from High Volatility Commercial Real Estate

Update to RFS Referee Payments

  • SFS News

Beginning April 1, 2022, referees will no longer accrue a payment balance for RFS. Referees will be paid for each report rather than being paid after their accounts reach the threshold. Submitting authors will no longer be able to apply their reviewer account balances to pay submission fees beginning April 1.

Forthcoming Papers

“The Burden of the National Debt: Evidence from Mergers and Acquisitions” by Ruchith Dissanayake, Yanhui Wu, and Huizhong Zhang “Social Change through Financial Innovation: Evidence from Donor-advised Funds” by Jillian Grennan

Dual Submissions with RCFS Winter Conference

The dual submission decisions for the RCFS Winter Conference have been sent. If you submitted your paper as a dual submission and did not receive your decision email, please contact us.

RCFS Keynote Speaker

RCFS is pleased to announce that Tarun Ramadorai (Imperial College London) will be the RCFS Keynote Speaker at Cavalcade North America 2022. The keynote will take place on Monday, May 23.

Paper Spotlight: Sharing R&D Risk in Healthcare via FDA Hedges

                          Recent estimates suggest that the cost of developing a single new drug in the biopharmaceutical sector is $2.6 billion, confirming the very large amounts of money that medical companies invest to develop a new treatment. Biomedical companies also face the risk of very low rates of success, not only due to the inherent scientific risk of developing… Read More »Paper Spotlight: Sharing R&D Risk in Healthcare via FDA Hedges

Decisions for SFS Cavalcade North America 2022

  • SFS News

The decisions for SFS Cavalcade North America 2022 have been sent. If you did not receive your decision, please contact us. We received 1433 submissions. The final program was highly selective, with an 9.4% acceptance rate. If you selected dual submission with RAPS or RCFS, you will receive a separate decision email from the journal in the next few weeks.

Paper Spotlight: Optimal Capital Structure with Imperfect Competition

Why do firms in the same industry often have different leverage levels? In the forthcoming paper “Optimal Capital Structure with Imperfect Competition,” Egor Matveyev and Alexei Zhdanov show that strategic interaction alone can generate this difference. The authors first exhibit a theoretical model in which two ex ante identical firms are deciding when to enter an industry and also how much debt to issue. The product price depends both on… Read More »Paper Spotlight: Optimal Capital Structure with Imperfect Competition

Forthcoming Papers

“Determinants of LGBTQ Corporate Policies” by Tanja Artiga Gonzalez, Paul Vincent Calluzzo, G. Nathan Dong, and Georg Granic “What’s good for women is good for science: Evidence from the American Finance Association” by Renee Adams and Michelle Lowry